Global Rx Intravenous Aspirin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Rx Intravenous Aspirin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Aspirin, also known as acetylsalicylic acid, is a type of salicylic acid that is commonly used as an analgesic, antipyretic and anti-inflammatory drug. It can also be used to treat certain inflammatory diseases, such as Kawasaki disease and pericardium. Inflammation, rheumatic fever, etc. Administration immediately after myocardial infarction can reduce the risk of death. It can also prevent platelets from agglutinating in damaged blood vessels and has an anticoagulant effect. Long-term low-dose administration to high-risk cardiovascular patients can prevent heart disease, stroke and thrombosis. Rx Intravenous Aspirin refers to aspirin that can be administered by intravenous injection.

Market Overview:

The latest research study on the global Rx Intravenous Aspirin market finds that the global Rx Intravenous Aspirin market reached a value of USD 255.32 million in 2022. It’s expected that the market will achieve USD 347.08 million by 2028, exhibiting a CAGR of 5.25% during the forecast period.

Opportunities

With the development of economy, people pay more and more attention to health. Governments of various countries continue to increase their capital investment in the medical field, and have issued a series of policies to support the development of the medical industry, and continuously improve the medical system. Aspirin is included in the World Health Organization's standard list of essential medicines and is one of the essential medicines in the basic public health system. For example, the aging of the population in China is serious. Due to the decline in the physical functions of the elderly, the incidence of related cardiovascular diseases and thrombotic diseases has increased. In response to this situation, the Chinese government has issued relevant medical policies to protect the health of the elderly, and aspirin has an inhibitory effect on platelet aggregation, can prevent thrombosis, and has a preventive effect on related cardiovascular diseases and thrombotic diseases. The government's support for the medical industry will benefit the development of the industry.

Region Overview:

China had the highest growth rate of all regions.

Company Overview:

Reyoung Pharmaceutical Co., Ltd. is one of the major players operating in the Rx Intravenous Aspirin market, holding a share of 5.66% in 2021.

Ruiyang Pharmaceutical Co., Ltd. was founded in 1966. The company has 16 penicillin powder injection workshops, cephalosporin powder preparation workshops, freeze-dried powder injection preparation workshops, penicillin raw material medicine workshops, cephalosporin raw material medicine workshops, solid preparation workshops, small volume injection workshops and Chinese medicine workshops. The production workshop has passed the national drug GMP certification.

Bioplus Life Sciences Private Limited operates as a pharmaceutical company. The Company offers biodha, glucosamine, sucrslose, liquorice, diosmectite, and DL-lusine acetylsalicylate, as well as provides healthcare products. Bioplus Life Science serves customers worldwide.

Segmentation Overview:

Among different product types, Arginine acetylsalicylate segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Pain segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Rx Intravenous Aspirin market covered in Chapter 3:

Hainan Huluwa Pharmaceutical Co., Ltd.
Lionco Pharmaceutical Group
Heilongjiang Taige Pharmaceutical Co., Ltd.
Bioplus Life Sciences
Reyoung Pharmaceutical Co., Ltd.
AnHui BBCA Pharmaceutical Co., Ltd.
China Meheco Kangli Phaema Co.,Ltd

In Chapter 4 and Chapter 14.2, on the basis of types, the Rx Intravenous Aspirin market from 2018 to 2029 is primarily split into:

Lysine acetylsalicylate
Arginine acetylsalicylate

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Rx Intravenous Aspirin market from 2018 to 2029 covers:

Inflammation
Acute Coronary Syndrome
Ischemic Stroke
Pain
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)